Contract Service Directory


Erfo





Company Headquarters


Italia

Contract Service Directory

    Related Content

    • Biologics, Proteins, Vaccines | Breaking News | Industry News
      Thermo Fisher Buys Novasep

      Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz

      Pays more than $800 million to expand global capacity and address growing demand for cell and gene therapy.
      Contract Pharma Staff 01.15.21

    • APIs | Breaking News | cGMP Manufacture | Fill/Finish | Industry News
      LSNE Expands Fill Finish and Lyophilization Ops

      LSNE Expands Fill Finish and Lyophilization Ops

      New automated fill line at Bedford Campus adds ready-to-use aseptic filling and freeze-dryer capacity.
      Contract Pharma Staff 01.14.21

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News | Parenterals
      Baxter, Novavax Ink Sterile Manufacturing Agreement

      Baxter, Novavax Ink Sterile Manufacturing Agreement

      CMO Baxter will help increase commercial production and promote access to Novavax' Covid-19 vax in UK and European markets.
      Contract Pharma Staff 01.11.21


    • Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
      Fujifilm to Invest $40M in New Facility

      Fujifilm to Invest $40M in New Facility

      State-of-the-art viral vector and advanced therapy process development and manufacturing facility will be located in Boston area.
      Contract Pharma Staff 01.05.21

    • Bio News | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News | Scale-up/Technology Transfer
      Sesen Bio Enters Mfg. and Supply Partnership with Qilu Pharma

      Sesen Bio Enters Mfg. and Supply Partnership with Qilu Pharma

      Technology transfer to Qilu anticipated to be completed in mid-2021.
      Contract Pharma Staff 12.09.20

    • Life Science Success Podcast: Matt Hicks


    • Aseptic Processing | Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Fill/Finish | Industry News | Injectables | Lyophilization | Parenterals
      Baxter Invests $50M to Expand Sterile Fill/Finish Manufacturing Operations

      Baxter Invests $50M to Expand Sterile Fill/Finish Manufacturing Operations

      Construction currently underway; expected to be completed in 2021.
      Contract Pharma Staff 11.24.20

    • A Potential “Marriage”

      A Potential “Marriage”

      Initiator companies and generics/CMOs working together.
      Emil W. Ciurczak, DoraMaxx Consulting 11.17.20

    • Injectables Firms Expand Capacity

      Injectables Firms Expand Capacity

      CDMOs see steriles demand grow.
      S. Harachand, Contributing Editor 11.17.20


    • Scale-up/Technology Transfer
      Ensuring Quality During the Transfer and Scale Up of Rx Drugs

      Ensuring Quality During the Transfer and Scale Up of Rx Drugs

      Defining the key parameters and considerations for a successful technology transfer.
      Tom Chang, President, Bora Pharmaceutical Laboratory Co. Ltd. 11.17.20

    • Bioassay Development | Biologics, Proteins, Vaccines | Drug Development | Facilities
      Opportunities in Synthetic Biology

      Opportunities in Synthetic Biology

      Les Tillack, CEO of Luina Bio, discusses how ‘synbio’ is driving growth in the biopharma industry.
      Contract Pharma Staff

    • Breaking News | Industry News | Promotions & Moves
      Cytovance Appoints CEO

      Cytovance Appoints CEO

      Bin Zhang has been with Cytovance as a member of the Board of Directors since 2018.
      Contract Pharma Staff 11.12.20


    • Lyophilization
      LSNE Contract Manufacturing – The Recognized Leader in Lyophilization and Sterile Manufacturing

    • Drug Development
      Embedding your Drug Strategy Within a Solid Foundation for Success

      Embedding your Drug Strategy Within a Solid Foundation for Success

      This whitepaper looks at the broad set of trends influencing pharmaceutical development and manufacturing strategy today.